Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial. [PDF]
Tavoulareas G +13 more
europepmc +1 more source
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders. [PDF]
Li F, Chen Q, Dai Y, Lu L.
europepmc +1 more source
Critical Evaluation of the Role of Transcription Factor RAR-Orphan Receptor-γt in the Development of Chronic Inflammatory Dermatological Diseases: A Promising Therapeutic Target. [PDF]
Pramanik A, Mondal P, Bhattacharyya S.
europepmc +1 more source
The emerging role of DNA methylation in the pathogenicity of bacterial pathogens. [PDF]
Ma Y-x, Wang X-d, Li X-m.
europepmc +1 more source
A new hope for patients with Huntington's disease? [PDF]
eClinicalMedicine.
europepmc +1 more source
Aleksandra Baran-Kooiker +2 more
openaire +1 more source
Role of interleukin 17 and T helper cells 17 cells as a new immune target and signalling in the pathogenesis and treatment of autoimmune thyroid diseases. [PDF]
He H +5 more
europepmc +1 more source
Regulatory insights on adeno-associated virus-based gene therapies, cell- and tissue-based products, and CAR-T cell therapies: report from the 8th Asia Partnership Conference of Regenerative Medicine, April 24, 2025. [PDF]
Tominaga S +8 more
europepmc +1 more source
What Do Oral Drugs Really Look Like? Dose Regimen, Pharmacokinetics, and Safety of Recently Approved Small-Molecule Oral Drugs. [PDF]
Brown DG.
europepmc +1 more source
Societal participation in the development of orphan drugs: a systematic review. [PDF]
Akodad S, De Smedt D, Stevens H.
europepmc +1 more source

